Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 18

1.

Neutrophils exacerbate tuberculosis infection in genetically susceptible mice.

Yeremeev V, Linge I, Kondratieva T, Apt A.

Tuberculosis (Edinb). 2015 Jul;95(4):447-51. doi: 10.1016/j.tube.2015.03.007. Epub 2015 Apr 9.

PMID:
25935122
2.

Lung-residing myeloid-derived suppressors display dual functionality in murine pulmonary tuberculosis.

Knaul JK, Jörg S, Oberbeck-Mueller D, Heinemann E, Scheuermann L, Brinkmann V, Mollenkopf HJ, Yeremeev V, Kaufmann SH, Dorhoi A.

Am J Respir Crit Care Med. 2014 Nov 1;190(9):1053-66. doi: 10.1164/rccm.201405-0828OC.

PMID:
25275852
3.

Type I IFN signaling triggers immunopathology in tuberculosis-susceptible mice by modulating lung phagocyte dynamics.

Dorhoi A, Yeremeev V, Nouailles G, Weiner J 3rd, Jörg S, Heinemann E, Oberbeck-Müller D, Knaul JK, Vogelzang A, Reece ST, Hahnke K, Mollenkopf HJ, Brinkmann V, Kaufmann SH.

Eur J Immunol. 2014 Aug;44(8):2380-93. doi: 10.1002/eji.201344219. Epub 2014 Jun 24.

4.

Prominent role for T cell-derived tumour necrosis factor for sustained control of Mycobacterium tuberculosis infection.

Allie N, Grivennikov SI, Keeton R, Hsu NJ, Bourigault ML, Court N, Fremond C, Yeremeev V, Shebzukhov Y, Ryffel B, Nedospasov SA, Quesniaux VF, Jacobs M.

Sci Rep. 2013;3:1809. doi: 10.1038/srep01809.

5.

Partial redundancy of the pattern recognition receptors, scavenger receptors, and C-type lectins for the long-term control of Mycobacterium tuberculosis infection.

Court N, Vasseur V, Vacher R, Frémond C, Shebzukhov Y, Yeremeev VV, Maillet I, Nedospasov SA, Gordon S, Fallon PG, Suzuki H, Ryffel B, Quesniaux VF.

J Immunol. 2010 Jun 15;184(12):7057-70. doi: 10.4049/jimmunol.1000164. Epub 2010 May 19.

6.

The adaptor molecule CARD9 is essential for tuberculosis control.

Dorhoi A, Desel C, Yeremeev V, Pradl L, Brinkmann V, Mollenkopf HJ, Hanke K, Gross O, Ruland J, Kaufmann SH.

J Exp Med. 2010 Apr 12;207(4):777-92. doi: 10.1084/jem.20090067. Epub 2010 Mar 29.

7.

Membrane TNF confers protection to acute mycobacterial infection.

Fremond C, Allie N, Dambuza I, Grivennikov SI, Yeremeev V, Quesniaux VF, Jacobs M, Ryffel B.

Respir Res. 2005 Nov 14;6:136.

8.

Fatal Mycobacterium tuberculosis infection despite adaptive immune response in the absence of MyD88.

Fremond CM, Yeremeev V, Nicolle DM, Jacobs M, Quesniaux VF, Ryffel B.

J Clin Invest. 2004 Dec;114(12):1790-9.

9.

Comparative analysis of different vaccine constructs expressing defined antigens from Mycobacterium tuberculosis.

Doherty TM, Olsen AW, Weischenfeldt J, Huygen K, D'Souza S, Kondratieva TK, Yeremeev VV, Apt AS, Raupach B, Grode L, Kaufmann S, Andersen P.

J Infect Dis. 2004 Dec 15;190(12):2146-53. Epub 2004 Nov 8.

PMID:
15551213
10.

Toll-like receptor pathways in the immune responses to mycobacteria.

Quesniaux V, Fremond C, Jacobs M, Parida S, Nicolle D, Yeremeev V, Bihl F, Erard F, Botha T, Drennan M, Soler MN, Le Bert M, Schnyder B, Ryffel B.

Microbes Infect. 2004 Aug;6(10):946-59. Review.

PMID:
15310472
11.

Proteins of the Rpf family: immune cell reactivity and vaccination efficacy against tuberculosis in mice.

Yeremeev VV, Kondratieva TK, Rubakova EI, Petrovskaya SN, Kazarian KA, Telkov MV, Biketov SF, Kaprelyants AS, Apt AS.

Infect Immun. 2003 Aug;71(8):4789-94.

12.

Deletion of the 19kDa antigen does not alter the protective efficacy of BCG.

Yeremeev VV, Stewart GR, Neyrolles O, Skrabal K, Avdienko VG, Apt AS, Young DB.

Tuber Lung Dis. 2000;80(6):243-7.

PMID:
11162765
13.

Comparative analysis of T lymphocytes recovered from the lungs of mice genetically susceptible, resistant, and hyperresistant to Mycobacterium tuberculosis-triggered disease.

Lyadova IV, Eruslanov EB, Khaidukov SV, Yeremeev VV, Majorov KB, Pichugin AV, Nikonenko BV, Kondratieva TK, Apt AS.

J Immunol. 2000 Nov 15;165(10):5921-31.

14.

Characterization of T cell clones derived from lymph nodes and lungs of Pseudomonas aeruginosa-susceptible and resistant mice following immunization with heat-killed bacteria.

Kondratieva TK, Kobets NV, Khaidukov SV, Yeremeev VV, Lyadova IV, Apt AS, Tam MF, Stevenson MM.

Clin Exp Immunol. 2000 Aug;121(2):275-82.

15.

The 19-kD antigen and protective immunity in a murine model of tuberculosis.

Yeremeev VV, Lyadova IV, Nikonenko BV, Apt AS, Abou-Zeid C, Inwald J, Young DB.

Clin Exp Immunol. 2000 May;120(2):274-9.

16.

An ex vivo study of T lymphocytes recovered from the lungs of I/St mice infected with and susceptible to Mycobacterium tuberculosis.

Lyadova I, Yeremeev V, Majorov K, Nikonenko B, Khaidukov S, Kondratieva T, Kobets N, Apt A.

Infect Immun. 1998 Oct;66(10):4981-8.

17.

Induction of a type 1 immune response to a recombinant antigen from Mycobacterium tuberculosis expressed in Mycobacterium vaccae.

Abou-Zeid C, Gares MP, Inwald J, Janssen R, Zhang Y, Young DB, Hetzel C, Lamb JR, Baldwin SL, Orme IM, Yeremeev V, Nikonenko BV, Apt AS.

Infect Immun. 1997 May;65(5):1856-62.

18.

Supplemental Content

Loading ...
Support Center